143
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Amelioration of Skewed Th1/Th2 Balance in Tumor-Bearing and Asthma-Induced Mice by Oral Administration of Agaricus blazei Extracts

, , &
Pages 747-760 | Published online: 20 Oct 2008

REFERENCES

  • J.-Y. Blay, N. Burdin, F. Rousset, G. Lenoir, P. Biron, and T. Philip. 1993. Serum interleukin-10 in non-Hodgkin's lymphoma: A prognostic factor. Blood 82 (7):2169–2174.
  • D.R. Smith, S.L. Kunkel, M.D. Burdick, C.A. Wilke, M.B. Orringer, I. Wliyter, and R.M. Strieter. 1994. Production of interleukin-10 by human bronchogenic carcinoma. Am. J. Pathol. 145 (1):18–25.
  • P. Pellegrini, A.M. Berghella, T. Del Beato, S. Cicia, D. Adorno, and C.U. Casciani. 1996. Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression. Cancer Immunol. Immunother. 42 (1):1–8.
  • R.J. O'Hara, J. Greenman, A.W. MacDonald, K.M. Gaskell, K.P. Topping, G.S. Duthie, M.J. Kerin, P.W. Lee, and J.R. Monson. 1998. Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production. Clin. Cancer Res. 4 (8):1943–1948.
  • F. De Vita, M. Orditura, G. Galizia, C. Romano, E. Lieto, P. Iodice, C. Tuccillo, and G Catalano. 2000. Serum interleukin-10 is an independent prognostic factor in advanced solid tumors. Oncol. Rep. 7 (2):357–361.
  • H. Takimoto, D. Wakita, K. Kawaguchi, and Y. Kumazawa. 2004. Potentiation of cytotoxic activity in naïve and tumor-bearing mice by oral administration of hot-water extracts from Agaricus blazei fruiting bodies. Biol. Pharm. Bull. 27 (3):404–406.
  • S. Romagnani. 1994. Regulation of the development of type-2 T-helper cells in allergy. Curr. Opin. Immunol. 6 (6):838–846.
  • A.J. Coyle, K. Wagner, C. Bertrand, S. Tsuyuki, J. Bews, and C. Heusser. 1996. Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: Inhibition by a non-anaphylactogenic anti-IgE antibody. J. Exp. Med. 183 (4):1303–1310.
  • A. Ray, and R.S. Cohn. 1999. Th2 cells and GATA-3 in asthma: New insights into the regulation of airway inflammation. J. Clin. Invest. 104 (8):985–993.
  • B.N. Lambrecht, M. De Veeman, A.J. Coyle, J.C. Gutierrez-Ramos, K. Thielemans, and R.A. Pauwels. 2000. Myeloid dendtritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J. Clin. Invest. 106 (4):551–559.
  • J. Stavnezer. 1996. Immunoglobulin class switching. Curr. Opin. Immunol. 8 (2):199–205.
  • D.B. Corry, and F. Kheradmand. 1999. Induction and regulation of the IgE response. Nature 402 (6760 Suppl):B18–B23.
  • L.B. Bacharier, and R.S. Geha. 2000. Molecular mechanisms of IgE regulation. J. Allergy Clin. Immunol. 105 (2 Pt 2):S547–S558.
  • E. Maggi. 1998. The TH1/TH2 paradigm in allergy. Immunotechnol. 3 (4):233–244.
  • D.A. Randolph, R. Stephens, C.J.L. Curruthers, and D.C. Chaplin. 1999. Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation. J. Clin. Invest. 104 (8):1021–1029.
  • G. Marone, G. Spadaro, C. Palumbo, and G. Condorelli. 1999. The anti-IgE/anti-FcεRIα autoantibody network in allergic and autoimmune diseases. Clin. Exp. Allergy 29 (1):17–27.
  • M. Kovarova, and J. Rivera. 2004. A molecular understanding of mast cell activation and the promise of anti-allergic therapeutics. Curr. Med. Chem. 11 (15):2083–2091.
  • S.Y. Eum, K. Maghni, Q. Hamid, H. Campbell, D.H. Eidelman, and J.G. Martin. 2003. Involvement of the cysteinyl-leukotrienes in allergen-induced airway eosinophilia and hypersensitiveness in the mouse. Am. J. Respir. Cell Mol. Biol. 28 (1):25–32.
  • R. Ryll, K. Watanabe, N. Fujiwara, H. Takimoto, R. Hasunuma, Y. Kumazawa, M. Okada, and I. Yano. 2001. Mycobacterial cord factor, but not sulfolipid, causes depletion of NKT cells and upregulation of CD11D1 on murine macrophages. Microbes Infect. 3 (8):611–619.
  • A.D. Luster, and J.V. Ravetch. 1987. Genomic characterization of a γ-interferon-inducing gene (IP-10) and identification of an interferon–inducible hypersensitive site. Mol. Cell. Biol. 7 (10):3723–3731.
  • J.M. Farber. 1997. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukocyte Biol. 61 (3):246–257.
  • J.F. Gauchat, S. Henchoz, G. Mazzei, J.P. Auby, T. Brunner, H. Blasey, P. Life, D. Talabot, L. Flores Romo, and J. Thompson. 1993. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365 (6444):340–343.
  • J.F. Gauchat, S. Henchoz, D. Fattah, G. Mazzei, J.P. Aubry, T. Jomotte, L. Dash, K. Page, R. Solari, and D. Aldebert. 1995. CD40 ligand is functionally expressed on human eosinophils. Eur. J. Immunol. 25 (3):863–865.
  • P.R. Burd, W.C. Thompson, E.E. Max, and F.C. Mills. 1995. Activated mast cells produce interleukin 13. J. Exp. Med. 181 (4):1373–1380.
  • A. Bendelac, M.N. Rivera, S.H. Park, and J.H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535–562.
  • L.B. Schwartz. 1990. Tryptase, a mediator of human mast cells. J. Allergy Clin. Immunol. 86 (4 Pt 2):594–598.
  • J.A. Nadel. 1991. Role of mast cell and neutrophils proteases in airway secretion. Am. Rev. Respir. Dis. 144 (3 Pt 2):S48–51.
  • K.F. Austen. 1995. The Paul Kallos Memorial Lecture. From slow-reacting substance of anaphylaxis to leukotriene C4 synthesis. Int. Arch. Allergy Immunol. 107 (1–3):19–24.
  • C.O. I BinghamII;, and K.F. Austen. 2000. Mast-cell responses in the development of asthma. J. Allergy Clin. Immunol. 105 (2 Pt 2):S527–S534.
  • E.N. Charlesworth. 1997. The role of basophils and mast cells in acute and late reactions in the skin. Allergy 52 (34 Suppl):31–43.
  • S.J. Galli. 1997. The Paul Kallos Memorial Lecture. The mast cell: A versatile effector cell for a challenging world. Int. Arch. Allergy Immunol. 113 (1–3):14–22.
  • S.J. Galli. 2000. Mast cells and basophils. Curr. Opin. Hematol. 7 (1):32–39.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.